RESUMO
Although the immunological response during infectious mononucleosis (IMN) has been studied in detail, little is known about the spread of Epstein-Barr virus (EBV) in lymphoid organs or the topographical distribution of the infected cells. In this study, EBV was detected in 11 lymph nodes, 4 tonsils, and 1 spleen of 16 patients with IMN. The predominant cell type positive for the EBV genome was identified as small lymphocytes localized chiefly within typical T areas, preferentially in perifollicular and interfollicular regions of the lymph node. A few endothelia of epithelioid venules were also found to be positive. Furthermore, a small number of sinus lining cells of lymph nodes exhibited labelling. Altogether, only a small number of cells, not exceeding 1 per cent of all cells, were infected with EBV. Our results show that only a small number of lymphocytes carry the EBV and that besides B lymphocytes, other cell constituents of lymphatic tissues are infected by EBV during IMN.
Assuntos
Herpesvirus Humano 4/isolamento & purificação , Mononucleose Infecciosa/microbiologia , Tecido Linfoide/microbiologia , Autorradiografia , Linfócitos B/microbiologia , Humanos , Imuno-Histoquímica , Linfonodos/microbiologia , Técnicas de Sonda Molecular , Hibridização de Ácido Nucleico , Tonsila Palatina/microbiologia , Baço/microbiologia , Linfócitos T/microbiologiaRESUMO
Angioimmunoblastic lymphadenopathy with dysproteinemia (AILD) or lymphogranulomatosis X is a lymphoproliferative disorder with a histological picture resembling that of reactive lesions but with frequent cytogenetic and molecular abnormalities characteristic of malignant T cell lymphoma. Clinically, the disease runs a fatal course in the majority of patients although occasional spontaneous remissions have been observed. Median survival approaches only 1 year even with the most effective treatment protocols implemented so far. Fewer than 20% of patients survive 5 years after diagnosis and cure seems exceedingly rare. High-dose chemotherapy (HDCT) followed by autologous bone marrow transplantation (ABMT) represents a promising new treatment modality for patients with advanced lymphoma conceivably including AILD. We report the first patient with relapsed AILD successfully treated by HDCT and ABMT. This 21-year-old male is alive and free of disease 27 months after ABMT with a Karnofsky score of 100%.
Assuntos
Antineoplásicos/uso terapêutico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Transtornos das Proteínas Sanguíneas/complicações , Transplante de Medula Óssea , Linfadenopatia Imunoblástica/terapia , Adulto , Transtornos das Proteínas Sanguíneas/metabolismo , Terapia Combinada , Ciclofosfamida/administração & dosagem , Relação Dose-Resposta a Droga , Doxorrubicina/administração & dosagem , Humanos , Linfadenopatia Imunoblástica/complicações , Linfadenopatia Imunoblástica/metabolismo , Masculino , Prednisona/administração & dosagem , Recidiva , Transplante Autólogo , Vincristina/administração & dosagemRESUMO
The unusual course of a boy with juvenile chronic myeloid leukaemia is presented. After bone marrow transplantation (BMT) from an unrelated donor followed by graft failure and subsequent stimulation by rhu GM-CFC and II-3, this patient experienced complete recovery of autologous haematopoiesis. At 17 months post-BMT the patient was off any therapy with completely normal blood counts and no signs of disease.
Assuntos
Fator Estimulador de Colônias de Granulócitos e Macrófagos/uso terapêutico , Interleucina-3/uso terapêutico , Leucemia Mielogênica Crônica BCR-ABL Positiva/terapia , Transplante de Medula Óssea , Hematopoese , Humanos , Lactente , Leucemia Mielogênica Crônica BCR-ABL Positiva/cirurgia , Masculino , Proteínas RecombinantesRESUMO
Cystic fibrosis (CF) basic research has been hampered by the lack of a suitable animal model and is therefore dependent on the availability of human tissue. To date, the basic defect remains unknown, however, over the last decade convincing data have been produced that link the defect to altered epithelial electrolyte transport. Moreover, recent results of DNA analysis could confirm that the putative CF gene product is indeed expressed in epithelial tissues. Unfortunately, epithelial cells are difficult to maintain in culture, especially transport-active epithelia tend to be short-lived. We have devised a simple method for the subculturing of nasal epithelium which has been shown to exhibit altered electrolyte transport in CF patients. Nasal epithelial cells were isolated from nasal polyps obtained at surgery by protease digestion. Subsequently, cells were plated in culture medium and irradiated mouse fibroblasts were added as a feeder layer after 48 h. After 5-15 d, epithelial cells could be subcultured without loosing their growth potential, and were continuously maintained in culture for up to 4 months. The cells were frozen in liquid nitrogen following standard methods. Growth could be reinstituted after thawing the epithelium. Subcultured and thawed cells were clearly characterized as of epithelial origin and distinguished from mesodermal cells by their reaction with antibodies against keratin, vimentin, and desmin.
Assuntos
Pólipos Nasais/patologia , Animais , Divisão Celular , Linhagem Celular , Células Cultivadas , Técnicas de Cultura/métodos , Células Epiteliais , Epitélio/patologia , Fibroblastos/citologia , Fibroblastos/fisiologia , Humanos , CamundongosRESUMO
We report the case of a boy with juvenile chronic myeloid leukemia (jCML), who after initial treatment with interferon alpha-2 (IFN) and hydroxyurea underwent bone marrow transplantation (BMT) from a matched unrelated donor complicated by graft failure. Subsequent stimulation of hematopoiesis by GM-CSF and IL-3 promoted autologous recovery. In contrast to the course of disease pre-BMT, the boy is now off any therapy remaining in complete remission more than 500 days after BMT.
Assuntos
Transplante de Medula Óssea , Fator Estimulador de Colônias de Granulócitos e Macrófagos/uso terapêutico , Hematopoese/efeitos dos fármacos , Fatores Imunológicos/uso terapêutico , Interleucina-3/uso terapêutico , Leucemia Mielogênica Crônica BCR-ABL Positiva/cirurgia , Medula Óssea/efeitos dos fármacos , Medula Óssea/patologia , Sobrevivência Celular , Terapia Combinada , Sinergismo Farmacológico , Fator Estimulador de Colônias de Granulócitos e Macrófagos/administração & dosagem , Fator Estimulador de Colônias de Granulócitos e Macrófagos/farmacologia , Humanos , Hidroxiureia/uso terapêutico , Fatores Imunológicos/farmacologia , Lactente , Interferon Tipo I/uso terapêutico , Interleucina-3/administração & dosagem , Interleucina-3/farmacologia , Leucemia Mielogênica Crônica BCR-ABL Positiva/tratamento farmacológico , Leucemia Mielogênica Crônica BCR-ABL Positiva/terapia , Masculino , Indução de RemissãoRESUMO
The production of protease by malignant cells has been held responsible for invasion. The effect of aprotinin, a broad-spectrum protease inhibitor, on malignant invasion was examined histologically in organotypical cocultures of precultured embryonic chick heart fragments with two human melanoma cell lines and one virus-transformed fetal mouse carcass cell line. In the presence of 400 KIU/ml aprotinin, invasion was still permissive, while in the comparison with 0.1 microgram/ml vincristine, a microtubule and directional motility inhibitor and a well-documented anti-invasive agent, invasion was completely stopped. Aprotinin remained stable in the culture medium so that the presence of invasion cannot be explained by low drug concentration. It is concluded that aprotinin-sensitive proteases are not implicated in invasion in vitro in the cell types investigated, and that this in vitro technique deserves further interest for the study of protease inhibitors in the mechanism of invasion.
Assuntos
Aprotinina/farmacologia , Invasividade Neoplásica , Inibidores de Proteases/farmacologia , Animais , Adesão Celular/efeitos dos fármacos , Transformação Celular Viral , Embrião de Galinha , Meios de Cultura , Humanos , Melanoma/patologia , Miocárdio/patologia , Inibidores da Tripsina/metabolismo , Células Tumorais Cultivadas , Vincristina/farmacologiaRESUMO
L 929 mouse fibroblasts were cultured as monolayers with different amounts of sodium fluoride, corresponding to those used therapeutically. Proliferation of the cells was inhibited in the logarithmic phase of cell growth. There was no change in the protein concentration in the cells, but the concentration of hydroxyproline containing substances in the cells increased while that of hexuronic acid containing substances decreased. The changes in proliferation and in the concentrations of hydroxyproline containing substances and hexuronic acid containing substances were statistically significant. Although the findings cannot be explained in detail it can be concluded that at therapeutic concentrations sodium fluoride has a definite action in contact with the fibroblast, the typical connective tissue cell. This dose dependant action corroborates clinical experience.